SGP · SpyGlass Pharma, Inc.
$26.51
+0.28 (+1.07%)
At close · Aug 21
Market Cap
$886.71M
Shares
33.45M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-06 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-10 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-14 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-26 | — | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-02-13 | 2026-02-12 | |
| 8-K | 2026-02-09 | 2026-02-05 |
Showing 1–11 of 11 filings
Key facts
CIK
1778922
CUSIP
85220G109
13F (30d)
51 filings
51 filers
Visit website
Investor relations